I3 Biomedical laboratories
Photo credit: I3 BioMedical Inc.
MIRABEL, Quebec, October 26, 2021 (GLOBE NEWSWIRE) – i3 BioMedical Inc. (www.i3biomedical.com) achieves the fastest and most efficient “kill rate” of SARS-CoV-2. TrioMed sets the standard for unparalleled superiority in active protection worldwide.
Virucidal technology developed by i3 BioMedical Inc. has been confirmed to deactivate over 99.9% of SARS-CoV-2 – the virus that causes COVID-19 – on the outer surface of TrioMed Active Medical products (including the mask ) within 5 minutes after 8 hours of sham use, based on independent virological testing conducted at the University of Toronto.
The scientists, led by Professor Scott Gray-Owen of the Department of Molecular Genetics at the University of Toronto’s Temerty School of Medicine, used the faculty’s high-tech level three (CL3) containment lab to test the effectiveness of the protective layer of TrioMed Active Medical products.
“Our tests confirmed that TrioMed Active technology deactivates over 99.9% of SARS-CoV-2 at the current fastest 5 minute test time when applying the virus after 8 hours of mask use” says Gray-Owen, who has no affiliation with the company or its employees.
“The TrioMed Active material was subjected to an exceptionally demanding protocol for a period of 8 hours in our laboratories representing extreme conditions of use for face masks, gowns and similar medical products, before being sent to the University, ”said Mohammed Belhaj, president of Atlas. Pharma inc. (Health Canada Registration # 102041-A)
“For more than a decade, TrioMed technology has offered the highest level of protection against many microorganisms to users around the world. For antimicrobial medical products, the “speed to kill” parameter is essential to offer real protection: a “kill rate” of 30 minutes to hours does not sufficiently protect the wearer, this means that the viruses remain infectious throughout this period. . Only an antimicrobial ‘kill rate’ of up to 5 minutes provides TRUE and TRUE protection, ”said Pierre Jean Messier, Executive Chairman of i3 BioMedical Inc.
TrioMed Active products have been systematically used and tested against numerous pathogenic bacteria and viruses for over 10 years with consistent results of killing (deactivating) over 99.9% within 5 minutes of all microbes tested.
TrioMed Active provides the benchmark of unmatched efficacy in active anti-bacterial and anti-viral protection technology
TrioMed Active Technology, visit www.triomed.com or send an e-mail to triomed@triomed.com
A photo accompanying this announcement is available on https://www.globenewswire.com/NewsRoom/AttachmentNg/fea5dd10-6960-4e9f-bc48-067c1340986c
“Coffeeaholic. Lifelong alcohol fanatic. Typical travel expert. Prone to fits of apathy. Internet trailblazer.”